B cell acute lymphoblastic leukemia/lymphoma

B cell acute lymphoblastic leukemia/lymphoma
Updated: 08/28/2024
© Jun Wang, MD, PhD

General features
  • Most common pediatric leukemia
  • Lymphoma is defined as localized disease with <20% lymphoblasts in marrow and peripheral blood
Clinical presentations
  • Abrupt stormy onset
  • Pancytopenia due to bone marrow depression
  • Bone symptoms: pain, tenderness
  • Lymphadenopathy
  • Internal organ involvement: hepatosplenomegaly, testicular involvement, central nervous system manifestations
Key Laboratory findings
Key morphological features of lymphoblast
  • Larger than normal lymphocytes
  • Scant cytoplasm
  • NO granules
  • NO Auer rods
Markers
  • CD34, CD99, TdT, bcl-2, CD19, CD79a, PAX5
Genetic abnormalities
  • Various
  • Hyperdipoidy (>50 chromosomes): Excellent prognosis with antimetabolite-based therapy
  • Hypodiploidy (< 44 chromosomes): Poor prognosis, high frequency of RAS pathway mutation
  • t(12;21)(p13;q22): ETV6-RUNX1
  • t(9;22)(q34;q11.2): bcl-abl1, prognosis improved with imatinib addition to intensive chemo
  •  t(4;11)(q21;q23): MLL-AFF (AF4)
  • Translocation involving cytokine receptor-like factor 2 (CRLF2): poor prognosis
  • JAK2 mutation (R683G: NOT as V617F seen in MPN): poor prognosis


Back to lymphoid neoplasms
Back to contents

Comments


  1. why not proper treatment for acute lymphoblastic leukemia
    acute lymphoblastic leukemia

    ReplyDelete
    Replies
    1. This blog is designed to help medical students learning basic pathology in their preclinical years, and for their preparation of COMLEX 1 and/or USMLE step 1. Treatment is barely needed, unless it is associated with specific pathogenesis, such as all-tran-retinoic acid for APL.

      Delete

Post a Comment

Popular posts from this blog

Contents

Anemia

Practice questions Anemia I